Canada · Health Canada Drug Product Database

PEGETRON

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
73948
DIN
02254581
Form
Capsule, Powder For Solution
Company as listed by source
MERCK CANADA INC
Source status
Cancelled Post Market (2017-10-05)
Source last updated
2026-08-06

Source-listed ingredients

  • RIBAVIRIN — 200 MG — per 1 CAP
  • PEGINTERFERON ALFA-2B — 80 MCG — per 0.5 ML

These values do not establish equivalence or a dose recommendation.

Packages

  • 2x0.675ml-56 Caps

Source and coverage

Open Health Canada Drug Product Database

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse Canada records →